The stock of Alphatec Holdings Inc (NASDAQ:ATEC) is a huge mover today! The stock decreased 12.57% or $0.68 on November 10, hitting $4.73. About 65,682 shares traded hands. Alphatec Holdings Inc (NASDAQ:ATEC) has risen 96.01% since April 8, 2016 and is uptrending. It has outperformed by 90.37% the S&P500.
The move comes after 5 months negative chart setup for the $38.89M company. It was reported on Nov, 10 by Barchart.com. We have $4.26 PT which if reached, will make NASDAQ:ATEC worth $3.89 million less.
Alphatec Holdings Inc (NASDAQ:ATEC) Ratings Coverage
Out of 2 analysts covering Alphatec Holdings Inc. (NASDAQ:ATEC), 0 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 0 are positive. Alphatec Holdings Inc. has been the topic of 3 analyst reports since August 5, 2015 according to StockzIntelligence Inc. Zacks downgraded Alphatec Holdings Inc (NASDAQ:ATEC) on Friday, August 7 to “Hold” rating. The stock of Alphatec Holdings Inc (NASDAQ:ATEC) earned “Underperform” rating by Northland Capital on Monday, March 14. On Wednesday, August 5 the stock rating was downgraded by Canaccord Genuity to “Hold”.
According to Zacks Investment Research, “Alphatec Holdings, Inc. is a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. The Company’s principal product offering includes a variety of spinal implant products and systems consisted of components, such as spine screws and rods, spinal spacers, plates, and various biologics offerings. Alphatec Holdings, Inc. is headquartered in Carlsbad, California.”
Insitutional Activity: The institutional sentiment increased to 0.67 in 2016 Q2. Its up 0.51, from 0.16 in 2016Q1. The ratio improved, as 8 funds sold all Alphatec Holdings Inc shares owned while 4 reduced positions. 3 funds bought stakes while 5 increased positions. They now own 14.37 million shares or 6.30% less from 15.34 million shares in 2016Q1.
Morgan Stanley holds 75,826 shares or 0% of its portfolio. Hightower Advsrs Limited Liability Co reported 118,375 shares or 0% of all its holdings. Blackrock Institutional Trust Na has 2.42 million shares for 0% of their US portfolio. Pacwest Fincl Mgmt, a Arizona-based fund reported 96,775 shares. Renaissance has 0% invested in the company for 1.05M shares. Retail Bank Of America Corp De accumulated 0% or 76,855 shares. Advisers Ltd Llc holds 0% of its portfolio in Alphatec Holdings Inc (NASDAQ:ATEC) for 49,949 shares. Goldman Sachs Gru reported 102,485 shares or 0% of all its holdings. The New Jersey-based Kcg has invested 0% in Alphatec Holdings Inc (NASDAQ:ATEC). Vanguard Group Inc Inc holds 0% or 2.84 million shares in its portfolio. Geode Capital Management Lc holds 0% or 306,249 shares in its portfolio. Globeflex Capital L P last reported 3,152 shares in the company. Manufacturers Life Com The owns 6,729 shares or 0% of their US portfolio. 1832 Asset Mgmt Limited Partnership owns 14,000 shares or 0% of their US portfolio. Deutsche State Bank Ag last reported 0% of its portfolio in the stock.
More notable recent Alphatec Holdings Inc (NASDAQ:ATEC) news were published by: Globenewswire.com which released: “Alphatec Holdings Announces Third Quarter 2016 Revenue and Financial Results” on November 09, 2016, also Marketwatch.com with their article: “/quotes/zigman/3870025/realtime” published on December 21, 2009, Streetinsider.com published: “Form 3 Alphatec Holdings, Inc. For: Oct 05 Filed by: Nelson Dennis” on November 09, 2016. More interesting news about Alphatec Holdings Inc (NASDAQ:ATEC) were released by: Reuters.com and their article: “BRIEF-Alphatec Holdings announces one-for-twelve reverse stock split” published on August 24, 2016 as well as Globenewswire.com‘s news article titled: “Alphatec Spine Introduces New Titanium-Coated PEEK Interbody Fusion System” with publication date: October 12, 2015.
ATEC Company Profile
Alphatec Holdings, Inc., incorporated on March 4, 2005, is a medical technology company. The Firm through its subsidiary, Alphatec Spine, Inc. and its subsidiaries (Alphatec Spine), designs, develops, makes and markets products for the surgical treatment of spine disorders. The Company’s product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. The Company’s principal product offerings are focused on the global market for fusion spinal disorder solutions. The Company’s products include Cervical and Cervico-Thoracic Products; Thoracolumbar Fixation Products; Spinal Spacers; minimally invasive surgery (MIS) Products, and Biologics.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.